For research use only. Not for human or veterinary use. Supplied as a lyophilized powder for laboratory research.
Selank vs Semax is a common comparison because both are synthetic heptapeptides developed by the same Russian research institutes and both end in the stabilizing Pro-Gly-Pro motif. They come from different parent molecules and have been studied through different mechanisms. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is an analog of the adrenocorticotropic hormone fragment ACTH(4-10) and has been studied for its effects on BDNF and its receptor trkB in rat brain [1][2]. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) has been studied mainly for gene-expression changes linked to GABAergic neurotransmission [3].
Selank vs Semax at a glance
| Selank | Semax | |
|---|---|---|
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro (PubChem CID 11765600) | Met-Glu-His-Phe-Pro-Gly-Pro [1] |
| Formula / MW | C₃₃H₅₇N₁₁O₉ / ~751.9 g/mol (PubChem) | C₃₇H₅₁N₉O₁₀S / ~813.9 g/mol (PubChem CID 9811102) |
| Parent sequence | Tuftsin analog (Thr-Lys-Pro-Arg extended with Pro-Gly-Pro) [6] | ACTH(4-10) analog [1] |
| Main research focus | GABAergic gene expression [3][4] | BDNF/trkB system [1][2] |
| FDA Category 2 | Selank acetate listed [5] | Semax listed [5] |
Semax research: BDNF and trkB
- Binding: tritium-labeled Semax showed specific, reversible, calcium-dependent binding in rat basal forebrain membranes, with a dissociation constant (KD) of about 2.4 nM [2].
- BDNF: in rat hippocampus, Semax produced a maximal 1.4-fold increase in BDNF protein and a 1.6-fold increase in trkB tyrosine phosphorylation, with 3-fold and 2-fold increases in exon III BDNF and trkB mRNA [1]. BDNF protein also rose in basal forebrain but not cerebellum [2].
- The authors connect these findings with learning-related behavior in rats [1].
Selank research: gene expression and GABA
- A 2016 rat study measured 84 neurotransmission-related genes in frontal cortex. Selank changed the expression of 45 genes at 1 hour and 22 at 3 hours, and the changes correlated with those produced by GABA [3].
- The authors propose allosteric modulation of the GABAergic system as one possible mechanism [3].
- A 2017 study examined Selank-related gene expression in the human neuroblastoma cell line IMR-32 [4].
Key differences for researchers
- Mechanistic focus: neurotrophin signaling for Semax; neurotransmission gene expression for Selank.
- Evidence base: both literatures are mostly rodent and cell studies, largely from one group of institutes; independent replication is limited.
- Neither peptide is FDA-approved, and both appear on FDA’s Category 2 list [5].
Frequently asked questions
Semax is an ACTH(4-10) analog studied for BDNF/trkB signaling; Selank is a tuftsin analog studied for GABA-related gene expression [1][3][6].
A synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, analogous to the ACTH(4-10) fragment [1].
A synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, studied for its effects on neurotransmission-related gene expression [3].
In rat studies, Semax increased BDNF protein in hippocampus (1.4-fold maximum) and basal forebrain [1][2].
Research materials and certificates
- Selank · Semax · COA Library
- Related: What Are Research Peptides? · How to Read a Peptide COA
References
- Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60. doi:10.1016/j.brainres.2006.07.108. PMID: 16996037
- Dolotov OV, Karpenko EA, Seredenina TS, et al. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem. 2006;97 Suppl 1:82-6. doi:10.1111/j.1471-4159.2006.03658.x. PMID: 16635254
- Volkova A, Shadrina M, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016;7:31. doi:10.3389/fphar.2016.00031. PMID: 26924987
- Filatova E, Kasian A, Kolomin T, et al. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Front Pharmacol. 2017;8:89. doi:10.3389/fphar.2017.00089. PMID: 28293190
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (Category 2). Content current as of 04/22/2026. fda.gov
- Kolomin TA, Agapova TIu, Agniullin IaV, et al. [Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank]. Zh Vyssh Nerv Deiat Im I P Pavlova. 2013;63(3):365-74. doi:10.7868/s0044467713030052. PMID: 24450168
Research-use-only disclaimer: All products from My Freedom Peptides are supplied as a lyophilized powder for laboratory research. They are for research use only and not for human or veterinary use. My Freedom Peptides LLC is a chemical supplier. It is not a 503A compounding pharmacy or a 503B outsourcing facility. These statements have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease.
